Search Results

You are looking at 1 - 10 of 685 items for :

  • "cardiovascular diseases" x
  • All content x
Clear All

Prevention of cardiovascular disease in the praxis. Recommendation of the Second Joint Task Force of European and other Societies on Coronary Prevention (In Hungarian). Published by Semmelweis University, Institute of Family Doctors and EGIS Pharmacological

Restricted access

1455 Wang, W., Lee, E. T., Fabsitz, R. R., et al.: A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study

Open access
Orvosi Hetilap
Authors: Nora Boussoussou, Melinda Boussoussou, László Entz, and Attila Nemes

Vargáné Hajdú, P., Ádány, R.: Trends of premature mortality from cardiovascular diseases in Hungary and the European Union, 1970–1997. [A keringési rendszer betegségei okozta korai halálozás trendjei

Open access
Orvosi Hetilap
Authors: Krisztián Vörös, Károly Cseh, and László Kalabay

disease in community-dwelling persons: the Rancho Bernardo Study. J. Am. Coll. Cardiol., 2011, 58 , 2372–2379. Wassel C. L. The associations of fetuin-A with subclinical cardiovascular

Open access

Digital risk analysis of cardiovascular diseases: new opportunities for the patients

A Szív-Érrendszeri Prevenciós Program (SZÉP©™) alkalmazása a gyakorlatban

Orvosi Hetilap
Authors: Csaba Arnold, Zoltán Englert, Csaba Szabadhegyi, and Csaba Farsang

Conroy, R. M., Pyöräl, K., Fitzgerald, A. P. és mtsai: On behalf of the SCORE project group: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J., 2003, 24 , 987

Restricted access
Orvosi Hetilap
Authors: Csaba Végh, Zoltán Langmár, Melinda Szerző, Annamária Ágota, Krisztina Marosi, Zoltán Szabolcs, and Zsolt B. Nagy

.: Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol., 2002, 155 , 487–495. Perveen G. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE

Open access

Lippi G, Franchini M, Favaloro EJ, Targher G: Moderate red wine consumption and cardiovascular disease risk: beyond the “French paradox”. Semin. Thromb. Hemost. 36, 59–70 (2010) Targher G Moderate red wine consumption and

Restricted access

118 2243 2251 Kawada, T.: Reynolds risk score as a risk assessment tool for cardiovascular disease after 10 years: Its strong

Restricted access

the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev., 2013 Jan 31. 1:CD009671. doi: 10.1002/14651858 Manzanares, W., Biestro, A., Galusso, F., et al.: Serum selenium and

Restricted access

Introduction Cardiovascular disease (CVD) is responsible for approximately 45% deaths in patients under hemodialysis, but its pathogenesis is very complex [ 1 ]. The event incidence of CVD is high in the first few weeks after initiation of

Restricted access